for Journals by Title or ISSN
for Articles by Keywords
help

Publisher: Elsevier   (Total: 3162 journals)

 A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 3 4 5 6 7 8 | Last   [Sort by number of followers]   [Restore default list]

Showing 1 - 200 of 3162 Journals sorted alphabetically
A Practical Logic of Cognitive Systems     Full-text available via subscription   (Followers: 9)
AASRI Procedia     Open Access   (Followers: 15)
Academic Pediatrics     Hybrid Journal   (Followers: 34, SJR: 1.655, CiteScore: 2)
Academic Radiology     Hybrid Journal   (Followers: 23, SJR: 1.015, CiteScore: 2)
Accident Analysis & Prevention     Partially Free   (Followers: 97, SJR: 1.462, CiteScore: 3)
Accounting Forum     Hybrid Journal   (Followers: 26, SJR: 0.932, CiteScore: 2)
Accounting, Organizations and Society     Hybrid Journal   (Followers: 37, SJR: 1.771, CiteScore: 3)
Achievements in the Life Sciences     Open Access   (Followers: 5)
Acta Anaesthesiologica Taiwanica     Open Access   (Followers: 7)
Acta Astronautica     Hybrid Journal   (Followers: 411, SJR: 0.758, CiteScore: 2)
Acta Automatica Sinica     Full-text available via subscription   (Followers: 2)
Acta Biomaterialia     Hybrid Journal   (Followers: 27, SJR: 1.967, CiteScore: 7)
Acta Colombiana de Cuidado Intensivo     Full-text available via subscription   (Followers: 2)
Acta de Investigación Psicológica     Open Access   (Followers: 3)
Acta Ecologica Sinica     Open Access   (Followers: 10, SJR: 0.18, CiteScore: 1)
Acta Haematologica Polonica     Free   (Followers: 1, SJR: 0.128, CiteScore: 0)
Acta Histochemica     Hybrid Journal   (Followers: 3, SJR: 0.661, CiteScore: 2)
Acta Materialia     Hybrid Journal   (Followers: 253, SJR: 3.263, CiteScore: 6)
Acta Mathematica Scientia     Full-text available via subscription   (Followers: 5, SJR: 0.504, CiteScore: 1)
Acta Mechanica Solida Sinica     Full-text available via subscription   (Followers: 9, SJR: 0.542, CiteScore: 1)
Acta Oecologica     Hybrid Journal   (Followers: 12, SJR: 0.834, CiteScore: 2)
Acta Otorrinolaringologica (English Edition)     Full-text available via subscription  
Acta Otorrinolaringológica Española     Full-text available via subscription   (Followers: 3, SJR: 0.307, CiteScore: 0)
Acta Pharmaceutica Sinica B     Open Access   (Followers: 1, SJR: 1.793, CiteScore: 6)
Acta Poética     Open Access   (Followers: 4, SJR: 0.101, CiteScore: 0)
Acta Psychologica     Hybrid Journal   (Followers: 28, SJR: 1.331, CiteScore: 2)
Acta Sociológica     Open Access   (Followers: 1)
Acta Tropica     Hybrid Journal   (Followers: 6, SJR: 1.052, CiteScore: 2)
Acta Urológica Portuguesa     Open Access  
Actas Dermo-Sifiliograficas     Full-text available via subscription   (Followers: 3, SJR: 0.374, CiteScore: 1)
Actas Dermo-Sifiliográficas (English Edition)     Full-text available via subscription   (Followers: 2)
Actas Urológicas Españolas     Full-text available via subscription   (Followers: 3, SJR: 0.344, CiteScore: 1)
Actas Urológicas Españolas (English Edition)     Full-text available via subscription   (Followers: 1)
Actualites Pharmaceutiques     Full-text available via subscription   (Followers: 6, SJR: 0.19, CiteScore: 0)
Actualites Pharmaceutiques Hospitalieres     Full-text available via subscription   (Followers: 3)
Acupuncture and Related Therapies     Hybrid Journal   (Followers: 6)
Acute Pain     Full-text available via subscription   (Followers: 14, SJR: 2.671, CiteScore: 5)
Ad Hoc Networks     Hybrid Journal   (Followers: 11, SJR: 0.53, CiteScore: 4)
Addictive Behaviors     Hybrid Journal   (Followers: 16, SJR: 1.29, CiteScore: 3)
Addictive Behaviors Reports     Open Access   (Followers: 8, SJR: 0.755, CiteScore: 2)
Additive Manufacturing     Hybrid Journal   (Followers: 9, SJR: 2.611, CiteScore: 8)
Additives for Polymers     Full-text available via subscription   (Followers: 22)
Advanced Drug Delivery Reviews     Hybrid Journal   (Followers: 151, SJR: 4.09, CiteScore: 13)
Advanced Engineering Informatics     Hybrid Journal   (Followers: 11, SJR: 1.167, CiteScore: 4)
Advanced Powder Technology     Hybrid Journal   (Followers: 17, SJR: 0.694, CiteScore: 3)
Advances in Accounting     Hybrid Journal   (Followers: 8, SJR: 0.277, CiteScore: 1)
Advances in Agronomy     Full-text available via subscription   (Followers: 14, SJR: 2.384, CiteScore: 5)
Advances in Anesthesia     Full-text available via subscription   (Followers: 28, SJR: 0.126, CiteScore: 0)
Advances in Antiviral Drug Design     Full-text available via subscription   (Followers: 2)
Advances in Applied Mathematics     Full-text available via subscription   (Followers: 10, SJR: 0.992, CiteScore: 1)
Advances in Applied Mechanics     Full-text available via subscription   (Followers: 11, SJR: 1.551, CiteScore: 4)
Advances in Applied Microbiology     Full-text available via subscription   (Followers: 24, SJR: 2.089, CiteScore: 5)
Advances In Atomic, Molecular, and Optical Physics     Full-text available via subscription   (Followers: 14, SJR: 0.572, CiteScore: 2)
Advances in Biological Regulation     Hybrid Journal   (Followers: 4, SJR: 2.61, CiteScore: 7)
Advances in Botanical Research     Full-text available via subscription   (Followers: 2, SJR: 0.686, CiteScore: 2)
Advances in Cancer Research     Full-text available via subscription   (Followers: 33, SJR: 3.043, CiteScore: 6)
Advances in Carbohydrate Chemistry and Biochemistry     Full-text available via subscription   (Followers: 8, SJR: 1.453, CiteScore: 2)
Advances in Catalysis     Full-text available via subscription   (Followers: 5, SJR: 1.992, CiteScore: 5)
Advances in Cell Aging and Gerontology     Full-text available via subscription   (Followers: 3)
Advances in Cellular and Molecular Biology of Membranes and Organelles     Full-text available via subscription   (Followers: 12)
Advances in Chemical Engineering     Full-text available via subscription   (Followers: 27, SJR: 0.156, CiteScore: 1)
Advances in Child Development and Behavior     Full-text available via subscription   (Followers: 10, SJR: 0.713, CiteScore: 1)
Advances in Chronic Kidney Disease     Full-text available via subscription   (Followers: 10, SJR: 1.316, CiteScore: 2)
Advances in Clinical Chemistry     Full-text available via subscription   (Followers: 29, SJR: 1.562, CiteScore: 3)
Advances in Colloid and Interface Science     Full-text available via subscription   (Followers: 19, SJR: 1.977, CiteScore: 8)
Advances in Computers     Full-text available via subscription   (Followers: 14, SJR: 0.205, CiteScore: 1)
Advances in Dermatology     Full-text available via subscription   (Followers: 15)
Advances in Developmental Biology     Full-text available via subscription   (Followers: 12)
Advances in Digestive Medicine     Open Access   (Followers: 9)
Advances in DNA Sequence-Specific Agents     Full-text available via subscription   (Followers: 5)
Advances in Drug Research     Full-text available via subscription   (Followers: 24)
Advances in Ecological Research     Full-text available via subscription   (Followers: 44, SJR: 2.524, CiteScore: 4)
Advances in Engineering Software     Hybrid Journal   (Followers: 28, SJR: 1.159, CiteScore: 4)
Advances in Experimental Biology     Full-text available via subscription   (Followers: 7)
Advances in Experimental Social Psychology     Full-text available via subscription   (Followers: 46, SJR: 5.39, CiteScore: 8)
Advances in Exploration Geophysics     Full-text available via subscription   (Followers: 1)
Advances in Fluorine Science     Full-text available via subscription   (Followers: 9)
Advances in Food and Nutrition Research     Full-text available via subscription   (Followers: 58, SJR: 0.591, CiteScore: 2)
Advances in Fuel Cells     Full-text available via subscription   (Followers: 16)
Advances in Genetics     Full-text available via subscription   (Followers: 16, SJR: 1.354, CiteScore: 4)
Advances in Genome Biology     Full-text available via subscription   (Followers: 8, SJR: 12.74, CiteScore: 13)
Advances in Geophysics     Full-text available via subscription   (Followers: 6, SJR: 1.193, CiteScore: 3)
Advances in Heat Transfer     Full-text available via subscription   (Followers: 23, SJR: 0.368, CiteScore: 1)
Advances in Heterocyclic Chemistry     Full-text available via subscription   (Followers: 12, SJR: 0.749, CiteScore: 3)
Advances in Human Factors/Ergonomics     Full-text available via subscription   (Followers: 22)
Advances in Imaging and Electron Physics     Full-text available via subscription   (Followers: 2, SJR: 0.193, CiteScore: 0)
Advances in Immunology     Full-text available via subscription   (Followers: 36, SJR: 4.433, CiteScore: 6)
Advances in Inorganic Chemistry     Full-text available via subscription   (Followers: 8, SJR: 1.163, CiteScore: 2)
Advances in Insect Physiology     Full-text available via subscription   (Followers: 2, SJR: 1.938, CiteScore: 3)
Advances in Integrative Medicine     Hybrid Journal   (Followers: 7, SJR: 0.176, CiteScore: 0)
Advances in Intl. Accounting     Full-text available via subscription   (Followers: 3)
Advances in Life Course Research     Hybrid Journal   (Followers: 8, SJR: 0.682, CiteScore: 2)
Advances in Lipobiology     Full-text available via subscription   (Followers: 1)
Advances in Magnetic and Optical Resonance     Full-text available via subscription   (Followers: 8)
Advances in Marine Biology     Full-text available via subscription   (Followers: 18, SJR: 0.88, CiteScore: 2)
Advances in Mathematics     Full-text available via subscription   (Followers: 11, SJR: 3.027, CiteScore: 2)
Advances in Medical Sciences     Hybrid Journal   (Followers: 6, SJR: 0.694, CiteScore: 2)
Advances in Medicinal Chemistry     Full-text available via subscription   (Followers: 5)
Advances in Microbial Physiology     Full-text available via subscription   (Followers: 4, SJR: 1.158, CiteScore: 3)
Advances in Molecular and Cell Biology     Full-text available via subscription   (Followers: 23)
Advances in Molecular and Cellular Endocrinology     Full-text available via subscription   (Followers: 8)
Advances in Molecular Toxicology     Full-text available via subscription   (Followers: 7, SJR: 0.182, CiteScore: 0)
Advances in Nanoporous Materials     Full-text available via subscription   (Followers: 3)
Advances in Oncobiology     Full-text available via subscription   (Followers: 1)
Advances in Organ Biology     Full-text available via subscription   (Followers: 1)
Advances in Organometallic Chemistry     Full-text available via subscription   (Followers: 17, SJR: 1.875, CiteScore: 4)
Advances in Parallel Computing     Full-text available via subscription   (Followers: 7, SJR: 0.174, CiteScore: 0)
Advances in Parasitology     Full-text available via subscription   (Followers: 5, SJR: 1.579, CiteScore: 4)
Advances in Pediatrics     Full-text available via subscription   (Followers: 24, SJR: 0.461, CiteScore: 1)
Advances in Pharmaceutical Sciences     Full-text available via subscription   (Followers: 12)
Advances in Pharmacology     Full-text available via subscription   (Followers: 16, SJR: 1.536, CiteScore: 3)
Advances in Physical Organic Chemistry     Full-text available via subscription   (Followers: 8, SJR: 0.574, CiteScore: 1)
Advances in Phytomedicine     Full-text available via subscription  
Advances in Planar Lipid Bilayers and Liposomes     Full-text available via subscription   (Followers: 3, SJR: 0.109, CiteScore: 1)
Advances in Plant Biochemistry and Molecular Biology     Full-text available via subscription   (Followers: 9)
Advances in Plant Pathology     Full-text available via subscription   (Followers: 5)
Advances in Porous Media     Full-text available via subscription   (Followers: 5)
Advances in Protein Chemistry     Full-text available via subscription   (Followers: 18)
Advances in Protein Chemistry and Structural Biology     Full-text available via subscription   (Followers: 20, SJR: 0.791, CiteScore: 2)
Advances in Psychology     Full-text available via subscription   (Followers: 64)
Advances in Quantum Chemistry     Full-text available via subscription   (Followers: 6, SJR: 0.371, CiteScore: 1)
Advances in Radiation Oncology     Open Access   (Followers: 1, SJR: 0.263, CiteScore: 1)
Advances in Small Animal Medicine and Surgery     Hybrid Journal   (Followers: 3, SJR: 0.101, CiteScore: 0)
Advances in Space Biology and Medicine     Full-text available via subscription   (Followers: 6)
Advances in Space Research     Full-text available via subscription   (Followers: 398, SJR: 0.569, CiteScore: 2)
Advances in Structural Biology     Full-text available via subscription   (Followers: 5)
Advances in Surgery     Full-text available via subscription   (Followers: 11, SJR: 0.555, CiteScore: 2)
Advances in the Study of Behavior     Full-text available via subscription   (Followers: 34, SJR: 2.208, CiteScore: 4)
Advances in Veterinary Medicine     Full-text available via subscription   (Followers: 17)
Advances in Veterinary Science and Comparative Medicine     Full-text available via subscription   (Followers: 13)
Advances in Virus Research     Full-text available via subscription   (Followers: 5, SJR: 2.262, CiteScore: 5)
Advances in Water Resources     Hybrid Journal   (Followers: 46, SJR: 1.551, CiteScore: 3)
Aeolian Research     Hybrid Journal   (Followers: 6, SJR: 1.117, CiteScore: 3)
Aerospace Science and Technology     Hybrid Journal   (Followers: 342, SJR: 0.796, CiteScore: 3)
AEU - Intl. J. of Electronics and Communications     Hybrid Journal   (Followers: 8, SJR: 0.42, CiteScore: 2)
African J. of Emergency Medicine     Open Access   (Followers: 6, SJR: 0.296, CiteScore: 0)
Ageing Research Reviews     Hybrid Journal   (Followers: 11, SJR: 3.671, CiteScore: 9)
Aggression and Violent Behavior     Hybrid Journal   (Followers: 455, SJR: 1.238, CiteScore: 3)
Agri Gene     Hybrid Journal   (Followers: 1, SJR: 0.13, CiteScore: 0)
Agricultural and Forest Meteorology     Hybrid Journal   (Followers: 17, SJR: 1.818, CiteScore: 5)
Agricultural Systems     Hybrid Journal   (Followers: 31, SJR: 1.156, CiteScore: 4)
Agricultural Water Management     Hybrid Journal   (Followers: 41, SJR: 1.272, CiteScore: 3)
Agriculture and Agricultural Science Procedia     Open Access   (Followers: 3)
Agriculture and Natural Resources     Open Access   (Followers: 3)
Agriculture, Ecosystems & Environment     Hybrid Journal   (Followers: 57, SJR: 1.747, CiteScore: 4)
Ain Shams Engineering J.     Open Access   (Followers: 5, SJR: 0.589, CiteScore: 3)
Air Medical J.     Hybrid Journal   (Followers: 6, SJR: 0.26, CiteScore: 0)
AKCE Intl. J. of Graphs and Combinatorics     Open Access   (SJR: 0.19, CiteScore: 0)
Alcohol     Hybrid Journal   (Followers: 11, SJR: 1.153, CiteScore: 3)
Alcoholism and Drug Addiction     Open Access   (Followers: 10)
Alergologia Polska : Polish J. of Allergology     Full-text available via subscription   (Followers: 1)
Alexandria Engineering J.     Open Access   (Followers: 1, SJR: 0.604, CiteScore: 3)
Alexandria J. of Medicine     Open Access   (Followers: 1, SJR: 0.191, CiteScore: 1)
Algal Research     Partially Free   (Followers: 11, SJR: 1.142, CiteScore: 4)
Alkaloids: Chemical and Biological Perspectives     Full-text available via subscription   (Followers: 2)
Allergologia et Immunopathologia     Full-text available via subscription   (Followers: 1, SJR: 0.504, CiteScore: 1)
Allergology Intl.     Open Access   (Followers: 5, SJR: 1.148, CiteScore: 2)
Alpha Omegan     Full-text available via subscription   (SJR: 3.521, CiteScore: 6)
ALTER - European J. of Disability Research / Revue Européenne de Recherche sur le Handicap     Full-text available via subscription   (Followers: 9, SJR: 0.201, CiteScore: 1)
Alzheimer's & Dementia     Hybrid Journal   (Followers: 51, SJR: 4.66, CiteScore: 10)
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring     Open Access   (Followers: 4, SJR: 1.796, CiteScore: 4)
Alzheimer's & Dementia: Translational Research & Clinical Interventions     Open Access   (Followers: 4, SJR: 1.108, CiteScore: 3)
Ambulatory Pediatrics     Hybrid Journal   (Followers: 6)
American Heart J.     Hybrid Journal   (Followers: 50, SJR: 3.267, CiteScore: 4)
American J. of Cardiology     Hybrid Journal   (Followers: 54, SJR: 1.93, CiteScore: 3)
American J. of Emergency Medicine     Hybrid Journal   (Followers: 45, SJR: 0.604, CiteScore: 1)
American J. of Geriatric Pharmacotherapy     Full-text available via subscription   (Followers: 10)
American J. of Geriatric Psychiatry     Hybrid Journal   (Followers: 14, SJR: 1.524, CiteScore: 3)
American J. of Human Genetics     Hybrid Journal   (Followers: 34, SJR: 7.45, CiteScore: 8)
American J. of Infection Control     Hybrid Journal   (Followers: 27, SJR: 1.062, CiteScore: 2)
American J. of Kidney Diseases     Hybrid Journal   (Followers: 35, SJR: 2.973, CiteScore: 4)
American J. of Medicine     Hybrid Journal   (Followers: 47)
American J. of Medicine Supplements     Full-text available via subscription   (Followers: 3, SJR: 1.967, CiteScore: 2)
American J. of Obstetrics and Gynecology     Hybrid Journal   (Followers: 211, SJR: 2.7, CiteScore: 4)
American J. of Ophthalmology     Hybrid Journal   (Followers: 65, SJR: 3.184, CiteScore: 4)
American J. of Ophthalmology Case Reports     Open Access   (Followers: 5, SJR: 0.265, CiteScore: 0)
American J. of Orthodontics and Dentofacial Orthopedics     Full-text available via subscription   (Followers: 6, SJR: 1.289, CiteScore: 1)
American J. of Otolaryngology     Hybrid Journal   (Followers: 25, SJR: 0.59, CiteScore: 1)
American J. of Pathology     Hybrid Journal   (Followers: 28, SJR: 2.139, CiteScore: 4)
American J. of Preventive Medicine     Hybrid Journal   (Followers: 28, SJR: 2.164, CiteScore: 4)
American J. of Surgery     Hybrid Journal   (Followers: 38, SJR: 1.141, CiteScore: 2)
American J. of the Medical Sciences     Hybrid Journal   (Followers: 12, SJR: 0.767, CiteScore: 1)
Ampersand : An Intl. J. of General and Applied Linguistics     Open Access   (Followers: 7)
Anaerobe     Hybrid Journal   (Followers: 4, SJR: 1.144, CiteScore: 3)
Anaesthesia & Intensive Care Medicine     Full-text available via subscription   (Followers: 62, SJR: 0.138, CiteScore: 0)
Anaesthesia Critical Care & Pain Medicine     Full-text available via subscription   (Followers: 17, SJR: 0.411, CiteScore: 1)
Anales de Cirugia Vascular     Full-text available via subscription  
Anales de Pediatría     Full-text available via subscription   (Followers: 3, SJR: 0.277, CiteScore: 0)
Anales de Pediatría (English Edition)     Full-text available via subscription  
Anales de Pediatría Continuada     Full-text available via subscription  
Analytic Methods in Accident Research     Hybrid Journal   (Followers: 5, SJR: 4.849, CiteScore: 10)
Analytica Chimica Acta     Hybrid Journal   (Followers: 42, SJR: 1.512, CiteScore: 5)
Analytical Biochemistry     Hybrid Journal   (Followers: 178, SJR: 0.633, CiteScore: 2)
Analytical Chemistry Research     Open Access   (Followers: 11, SJR: 0.411, CiteScore: 2)
Analytical Spectroscopy Library     Full-text available via subscription   (Followers: 11)
Anesthésie & Réanimation     Full-text available via subscription   (Followers: 2)
Anesthesiology Clinics     Full-text available via subscription   (Followers: 23, SJR: 0.683, CiteScore: 2)
Angiología     Full-text available via subscription   (SJR: 0.121, CiteScore: 0)
Angiologia e Cirurgia Vascular     Open Access   (Followers: 1, SJR: 0.111, CiteScore: 0)
Animal Behaviour     Hybrid Journal   (Followers: 197, SJR: 1.58, CiteScore: 3)

        1 2 3 4 5 6 7 8 | Last   [Sort by number of followers]   [Restore default list]

Journal Cover
Advances in Radiation Oncology
Journal Prestige (SJR): 0.263
Citation Impact (citeScore): 1
Number of Followers: 1  

  This is an Open Access Journal Open Access journal
ISSN (Online) 2452-1094
Published by Elsevier Homepage  [3162 journals]
  • Cochlea-sparing acoustic neuroma treatment with 4π radiation therapy

    • Authors: Kaley Woods; Percy Lee, Tania Kaprealian, Isaac Yang, Ke Sheng
      Pages: 100 - 107
      Abstract: This study investigates whether 4π noncoplanar radiation therapy can spare the cochleae and consequently potentially improve hearing preservation in patients with acoustic neuroma who are treated with radiation therapy.
      Citation: Advances in Radiation Oncology 3, 2 (2018)
      PubDate: 2018-02-05
      DOI: 10.1016/j.adro.2018.01.004
      Issue No: Vol. 3, No. 2 (2018)
       
  • Lung cancer specialists' opinions on treatment for stage I non-small cell
           lung cancer: A multidisciplinary survey

    • Authors: Austin Lammers; Timur Mitin, Drew Moghanaki, Charles R. Thomas, Robert Timmerman, Sara E. Golden, Sujata Thakurta, Rafal Dziadziuszko, Christopher G. Slatore
      Pages: 125 - 129
      Abstract: The current standard of care for surgically eligible stage I non-small cell lung cancer (NSCLC) is surgical resection, but emerging data suggest that stereotactic body radiation therapy (SBRT) is potentially as effective as surgery. However, specialist views of the current evidence about SBRT and how they would incorporate a randomized controlled trial (RCT) into practice is unclear. We sought to understand specialist opinions about evidence regarding treatment of stage I NSCLC and how this translates into practice and clinical trial implementation.
      Citation: Advances in Radiation Oncology 3, 2 (2018)
      PubDate: 2018-01-21
      DOI: 10.1016/j.adro.2018.01.001
      Issue No: Vol. 3, No. 2 (2018)
       
  • Serum cytokine profiles and metabolic tumor burden in patients with
           non-small cell lung cancer undergoing palliative thoracic radiation
           therapy

    • Authors: Hanne A. Eide; Ingerid Skjei Knudtsen, Vandana Sandhu, Ayca M. Løndalen, Ann Rita Halvorsen, Azadeh Abravan, Elin H. Kure, Trond V. Bogsrud, Odd Terje Brustugun, Jon Amund Kyte, Eirik Malinen, Åslaug Helland
      Pages: 130 - 138
      Abstract: Radiation therapy effectively kills cancer cells and elicits local effects in the irradiated tissue. The aim of this study was to investigate the kinetics of cytokines in the serum of patients with lung cancer undergoing radiation therapy and to identify associations with metabolic tumor burden as determined by 2-deoxy-2-fluoro-D-glucose (18F-FDG) positron emission tomography (PET).
      Citation: Advances in Radiation Oncology 3, 2 (2018)
      PubDate: 2018-02-13
      DOI: 10.1016/j.adro.2017.12.007
      Issue No: Vol. 3, No. 2 (2018)
       
  • Postresection CA19-9 and margin status as predictors of recurrence after
           adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG
           trial 9704

    • Authors: William F. Regine; Kathryn Winter, Ross A. Abrams, Howard Safran, Ivan L. Kessel, Yuhchyau Chen, James A. Fugazzi, Eric D. Donnelly, Thomas A. DiPetrillo, Samir Narayan, John P. Plastaras, Rakesh Gaur, Guila Delouya, John H. Suh, Joshua E. Meyer, Michael G. Haddock, Mukund S. Didolkar, Gilbert D.A. Padula, David Johnson, John P. Hoffman, Christopher H. Crane
      Pages: 154 - 162
      Abstract: NRG Oncology RTOG 9704 was the first adjuvant trial to validate the prognostic value of postresection CA19-9 levels for survival in patients with pancreatic carcinoma. The data resulting from this study also provide information about predictors of recurrence that may be used to tailor individualized management in this disease setting. This secondary analysis assessed the prognostic value of postresection CA19-9 and surgical margin status (SMS) in predicting patterns of disease recurrence.
      Citation: Advances in Radiation Oncology 3, 2 (2018)
      PubDate: 2018-02-09
      DOI: 10.1016/j.adro.2018.01.003
      Issue No: Vol. 3, No. 2 (2018)
       
  • Factors influencing prostate cancer patterns of care: An analysis of
           treatment variation using the SEER database

    • Authors: Lindsay M. Burt; Dennis C. Shrieve, Jonathan D. Tward
      Pages: 170 - 180
      Abstract: The aim of this study is to describe the trends and factors that influence the initial treatment of men with localized prostate cancer (PC) in the United States between 2004 and 2014.
      Citation: Advances in Radiation Oncology 3, 2 (2018)
      PubDate: 2018-01-19
      DOI: 10.1016/j.adro.2017.12.008
      Issue No: Vol. 3, No. 2 (2018)
       
  • Promoting safety mindfulness: Recommendations for the design and use of
           simulation-based training in radiation therapy

    • Authors: Lukasz M. Mazur; Lawrence B. Marks, Ron McLeod, Waldemar Karwowski, Prithima Mosaly, Gregg Tracton, Robert D. Adams, Lesley Hoyle, Shiva Das, Bhishamjit Chera
      Pages: 197 - 204
      Abstract: There is a need to better prepare radiation therapy (RT) providers to safely operate within the health information technology (IT) sociotechnical system. Simulation-based training has been preemptively used to yield meaningful improvements during providers' interactions with health IT, including RT settings. Therefore, on the basis of the available literature and our experience, we propose principles for the effective design and use of simulated scenarios and describe a conceptual framework for a debriefing approach to foster successful training that is focused on safety mindfulness during RT professionals' interactions with health IT.
      Citation: Advances in Radiation Oncology 3, 2 (2018)
      PubDate: 2018-02-07
      DOI: 10.1016/j.adro.2018.01.002
      Issue No: Vol. 3, No. 2 (2018)
       
  • Saving the hand: Role of multimodality therapy for Ewing's sarcoma family
           tumor of the palm

    • Authors: Sanjay A. Joseph; Rahul Bhandari, Ashley Albert, James Jackson, Madhava Kanakamedala, Robert D. Hamilton, Jennifer Barr, Srinivasan Vijayakumar
      Pages: 205 - 208
      Abstract: The Ewing's sarcoma family of tumors (EFTs) are a rare subtype of tumor that include primitive neuroectodermal tumors (PNETs), typical Ewing's sarcoma, and atypical Ewing sarcoma. EFTs of the hand are extremely rare, and none have been reported to our knowledge beyond the fifth decade of life.1-3 EFTs present most frequently in the second decade of life and have a male predominance.3 Multimodality therapy is typically used to treat patients.
      Citation: Advances in Radiation Oncology 3, 2 (2018)
      PubDate: 2018-02-09
      DOI: 10.1016/j.adro.2018.01.005
      Issue No: Vol. 3, No. 2 (2018)
       
  • Salvage re-irradiation for local failure of prostate cancer after curative
           radiation therapy: association of rectal toxicity with dose distribution
           and NTCP models

    • Authors: Giovanna Dipasquale; Thomas Zilli, Claudio Fiorino, Michel Rouzaud, Raymond Miralbell
      Abstract: To assess the impact of radiation dose on rectal toxicity following salvage external beam radiation therapy (EBRT) with or without a brachytherapy (BT) boost for exclusive local failures after primary-EBRT for prostate cancer.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-06-15
      DOI: 10.1016/j.adro.2018.06.001
       
  • Kilo-voltage projection streaming-based tracking application (KiPSTA):
           first clinical implementation during spine stereotactic radiosurgery

    • Authors: Jihun Kim; Yang-Kyun Park, David Edmunds, Kevin Oh, Gregory Sharp, Brian Winey
      Abstract: To develop a linac-mounted kilo-voltage (kV) projection streaming-based tracking method for vertebral targets during spine stereotactic radiosurgery (SRS) and to evaluate the clinical feasibility of the proposed spine tracking method.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-06-07
      DOI: 10.1016/j.adro.2018.06.002
       
  • Risk factors for late bowel and bladder toxicities in NRG Oncology
           prostate cancer trials of high-risk patients: A meta-analysis of
           physician-rated toxicities

    • Authors: Canhua Xiao; Jennifer Moughan, Benjamin Movsas, Andre A. Konski, Gerald E. Hanks, James D. Cox, Mack Roach, Kenneth L. Zeitzer, Colleen A. Lawton, Christopher A. Peters, Seth A. Rosenthal, I.-Chow Joe Hsu, Eric M. Horwitz, Mark V. Mishra, Jeff M. Michalski, Matthew B. Parliament, David P. D'Souza, Stephanie L. Pugh, Deborah W. Bruner
      Abstract: A meta-analysis of sociodemographic variables and their association with late (>180 days from start of radiation therapy[RT]) bowel, bladder, and clustered bowel and bladder toxicities was conducted in patients with high-risk (clinical stages T2c-T4b or Gleason score 8-10 or prostate-specific antigen level >20) prostate cancer.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-06-07
      DOI: 10.1016/j.adro.2018.04.010
       
  • Osteoradionecrosis of the jaw in a patient with lymphoma treated with
           rituximab and concomitant involved field radiation therapy

    • Authors: Jesus D. Gonzalez-Lugo; Rafi Kabarriti, Ioannis Mantzaris
      Abstract: Most guidelines recommend radiation therapy for the treatment of early stage (I/II), grade 1-3A follicular lymphoma (FL).1,2 This recommendation is mostly based on retrospective studies in the pre-rituximab era, showing long-term disease-free survival with extended field radiation therapy and subsequently involved field radiation therapy (IFRT).3-8
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-06-04
      DOI: 10.1016/j.adro.2018.05.008
       
  • Soluble interleukin-6 receptor mediated fatigue highlights immunological
           heterogeneity of patients with early breast cancer patients undergoing
           radiotherapy

    • Authors: Nicholas Courtier; Tina Gambling, Peter Barrett-Lee, Malcolm D. Mason
      Abstract: To explore the associations between dose-volume parameters of localised breast irradiation, longitudinal systemic interleukin-6 soluble receptor (sIL-6R) and leukocyte counts as markers of an immune-mediated response and fatigue as a centrally-driven behaviour.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-31
      DOI: 10.1016/j.adro.2018.05.007
       
  • Complete response of pleural effusions caused by extramedullary
           hematopoiesis to low-dose, single fraction palliative radiation therapy:
           case report and literature review

    • Authors: Hunter C. Gits; Scott Lester, Laura A. McGrath, James A. Martenson
      Abstract: Pulmonary extramedullary hematopoiesis, either in the lung parenchyma or in the pleura, is an unusual sequela of marrow-depleting disorders that can precipitate symptomatic compromise of the respiratory system. In case reports of patients with pulmonary extramedullary hematopoiesis, low dose external beam radiotherapy targeting the lungs has been shown to palliate respiratory symptoms and control pulmonary extramedullary hematopoiesis-associated pleural effusions with mixed results.(1–11) Here we present a case of symptomatic, bilateral pulmonary extramedullary hematopoiesis-associated pleural effusions effectively managed with low dose radiotherapy.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-25
      DOI: 10.1016/j.adro.2018.04.012
       
  • Stereotactic body radiotherapy for adrenal gland metastases: outcomes and
           toxicity

    • Authors: Diego A.S. Toesca; Amanda J. Koong, Rie von Eyben, Albert C. Koong, Daniel T. Chang
      Abstract: To report our institutional experience in the use of stereotactic body radiotherapy (SBRT) for treatment of adrenal gland metastases, specifically examining outcomes and toxicity from this treatment modality on adjacent organs-at-risk.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-24
      DOI: 10.1016/j.adro.2018.05.006
       
  • Multi-institutional report on toxicities of concurrent nivolumab and
           radiation therapy

    • Authors: Neha P. Amin; Maliha Zainib, Sean Parker, Manuj Agarwal, Malcom Mattes
      Abstract: Radiation therapy (RT) and nivolumab are both standard therapies for a wide range of advanced and metastatic cancers, yet little is known about the toxicity profile of their combined treatment. The rate of Grade 3 or higher toxicities from nivolumab monotherapy and radiation-only palliative treatments has been reported at 10-18% and 0-26%, respectively. We reviewed our experience to assess the acute toxicity profile of concurrent RT-nivolumab.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-24
      DOI: 10.1016/j.adro.2018.04.015
       
  • Brain metastases with poor vascular function are susceptible to
           pseudoprogression following stereotactic radiosurgery

    • Authors: Ingrid Digernes; Endre Grøvik, Line B. Nilsen, Cathrine Saxhaug, Oliver Geier, Edmund Reitan, Dag Ottar Sætre, Birger Breivik, Timothy Reese, Kari Dolven Jacobsen, Åslaug Helland, Kyrre Eeg Emblem
      Abstract: To investigate the hemodynamic status of cerebral metastases prior to and after stereotactic radiosurgery (SRS) and identify vascular characteristics associated with development of pseudoprogression from radiation-induced damage with and without a radionecrotic component.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-17
      DOI: 10.1016/j.adro.2018.05.005
       
  • A simulation study to assess the potential impact of developing NTCP
           models with accumulated dose

    • Authors: Molly M. McCulloch; Daniel G. Meunz, Matthew J. Schipper, Michael Velec, Laura A. Dawson, Kristy K. Brock
      Abstract: Analyze the potential clinical impact of differences between planned and accumulated dose on the development and use of normal tissue complication probability (NTCP) models.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-17
      DOI: 10.1016/j.adro.2018.05.003
       
  • Inter-observer reliability in describing radiographic lung changes after
           stereotactic body radiotherapy

    • Authors: Noah S. Kalman; Geoffrey D. Hugo, Jenna M. Kahn, Sherry S. Zhao, Nuzhat Jan, Rebecca N. Mahon, Elisabeth Weiss
      Abstract: Radiographic lung changes after stereotactic body radiotherapy (SBRT) vary widely between patients. Standardized descriptions of acute (≤6 months after treatment) and late (>6 months after treatment) benign lung changes have been proposed, but the reliable application of these classification systems has not been demonstrated. Herein we examine the inter-observer reliability of classifying acute and late lung changes after SBRT.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-15
      DOI: 10.1016/j.adro.2018.05.004
       
  • Definitive hypofractionated radiotherapy for early stage breast cancer:
           dosimetric feasibility of stereotactic ablative radiosurgery (SABR) and
           proton beam therapy (PBT) for intact breast tumors

    • Authors: Jonathan W. Lischalk; Hao Chen, Michael C. Repka, Lloyd D. Campbell, Olusola Obayomi-Davies, Shaan Kataria, Thomas P. Kole, Sonali Rudra, Brian T. Collins
      Abstract: In this manuscript we report the dosimetric feasibility of definitive stereotactic ablative radiosurgery and proton beam therapy for small breast tumors utilizing hypofractionated partial breast radiotherapy. Based on our analysis of a small number of patients with disease visible by CT imaging and utilizing established dosimetric constraints, these novel techniques appear to be dosimetrically feasible and provide unique normal tissue sparing.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-11
      DOI: 10.1016/j.adro.2018.05.002
       
  • Safety of combining thoracic radiotherapy with concurrent versus
           sequential immune checkpoint inhibition

    • Authors: Donata von Reibnitz; Jamie E. Chaft, Abraham J. Wu, Robert Samstein, Matthew D. Hellmann, Andrew J. Plodkowski, Zhigang Zhang, Weiji Shi, Rosalind Dick-Godfrey, Kelly H. Panchoo, Christopher A. Barker, Andreas Rimner
      Abstract: The objective of this study was to evaluate adverse events (AEs) in patients receiving both immune checkpoint inhibitors and thoracic radiation therapy (RT). In particular, we compared the rate of toxicities of concurrent versus sequential delivery of thoracic RT and checkpoint inhibitors.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-09
      DOI: 10.1016/j.adro.2018.05.001
       
  • Radiomics-guided therapy for bladder cancer: using an optimal biomarker
           approach to determine extent of bladder cancer invasion from T2-weighted
           MR images

    • Authors: Yubing Tong; Jayaram K. Udupa, Chuang Wang, Jerry Chen, Sriram Venigalla, Thomas J. Guzzo, Ronac Mamtani, Brian C. Baumann, John P. Christodouleas, Drew A. Torigian
      Abstract: Current clinical staging methods are unable to accurately define the extent of invasion of localized bladder cancer, which affects the proper use of systemic therapy, surgery and radiation. Our purpose was to test a novel radiomics approach to identify optimal imaging biomarkers from T2-weighted MR images that accurately classify localized bladder cancer into two tumor (T) stage groups (≤ T2 vs > T2) at both the patient level and within bladder sub-sectors.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-08
      DOI: 10.1016/j.adro.2018.04.011
       
  • Late toxicity after post-prostatectomy intensity modulated radiation
           therapy: evaluating normal-tissue sparing guidelines

    • Authors: Adil S. Akthar; Anthony C. Wong, Akash D. Parekh, Greg Hubert, Christina H. Son, Charles A. Pelizzari, Stanley L. Liauw
      Abstract: Dose-volume histogram (DVH)-toxicity relationships are poorly defined in men receiving radiation after radical prostatectomy (RP). We evaluated RTOG 0534 and institutional intact normal tissue-sparing guidelines, as well as dose to the bladder trigone, for their ability to minimize late toxicity.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-08
      DOI: 10.1016/j.adro.2018.04.009
       
  • Skin recurrence in radiation treatment of breast cancer

    • Authors: Leah M. Katz; Carmen Perez, Naamit Gerber, Juhi Purswani, Allison McCarthy, Indra J. Das
      Abstract: Locoregional skin recurrence for early-stage, node negative, hormone receptor positive breast cancer patients after lumpectomy, sentinel lymph node sampling, and adjuvant radiation, is exceedingly rare. However, the recurrence is directly related to inadequate skin dose and should be monitored and augmented with proper technique to avoid complication.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-07
      DOI: 10.1016/j.adro.2018.04.014
       
  • Racial disparities in guideline-concordant cancer care and mortality in
           the United States

    • Authors: Penny Fang; Weiguo He, Daniel Gomez, Karen E. Hoffman, Benjamin D. Smith, Sharon H. Giordano, Reshma Jagsi, Grace L. Smith
      Abstract: We identified the frequency of racial disparities in guideline-concordant cancer care for select common disease sites in the US and the impact of guideline-concordance on mortality disparities.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-05-04
      DOI: 10.1016/j.adro.2018.04.013
       
  • Autoradiography and biopsy measurements of a resected hepatocellular
           carcinoma treated with 90Y radioembolization demonstrate large absorbed
           dose heterogeneities

    • Authors: Jens Hemmingsson; Jonas Högberg, Johan Mölne, Johanna Svensson, Peter Gjertsson, Magnus Rizell, Olof Henrikson, Peter Bernhardt
      Abstract: Radioembolization is an alternative palliative treatment for hepatocellular carcinoma. Here we examine uptake differences between tumor tissue phenotypes and present a cross section of the absorbed dose throughout a liver tissue specimen.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-04-30
      DOI: 10.1016/j.adro.2018.04.008
       
  • Quantitative clinical outcomes of head and neck lymphedema therapy

    • Authors: Kaleigh N. Doke; Laine Bowman, Lisa Shnayder, Xinglei Shen, Mindi TenNapel, Sufi Thomas, Prakash Neupane, Hung-Wen Yeh, Chris E. Lominska
      Abstract: Head and neck surgery and radiation cause tissue fibrosis leading to functional limitations and lymphedema. The objective of this study was to determine whether lymphedema therapy following surgery and radiation for head and neck cancer decreases neck circumference, increases cervical range of motion and improves pain scores.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-04-27
      DOI: 10.1016/j.adro.2018.04.007
       
  • Using benchmarked lung radiation dose constraints to predict pneumonitis
           risk: developing a nomogram for patients with mediastinal lymphoma

    • Authors: Chelsea C. Pinnix; Jinhai Huo, Sarah A. Milgrom, Zeinab Abou Yehia, Michelle Fanale, Yasuhiro Oki, Bouthaina S. Dabaja, Grace L. Smith
      Abstract: We identified lung dosimetric constraints to assist in predicting radiation pneumonitis (RP) risk in mediastinal lymphoma patients and then identified clinical prognostic factors associated with achievement of key dosimetric constraints.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-04-24
      DOI: 10.1016/j.adro.2018.03.005
       
  • Is completion axillary lymph node dissection necessary in patients
           underrepresented in ACOSOG z0011 trial'

    • Authors: Brian J. Gebhardt; Joel Thomas, Zachary D. Horne, Colin E. Champ, Daniel J. Farrugia, Emilia Diego, Gretchen M. Ahrendt, Sushil Beriwal
      Abstract: ACOSOG Z0011 demonstrated that axillary node dissection (ALND) can be omitted in patients managed with breast conserving surgery and 1-2 positive sentinel lymph nodes (SLNs) without adverse effects on loco-regional recurrence or disease-free survival. We investigated breast cancer patients with clinicopathologic features underrepresented in Z0011 and analyzed RT treatment patterns and clinical outcomes.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-04-24
      DOI: 10.1016/j.adro.2018.03.004
       
  • Palliative radiation and fractionation in medicare patients with incurable
           non-small cell lung cancer

    • Authors: Miranda B. Lam; Ling Li, Angel Cronin, Deborah Schrag, Aileen B. Chen
      Abstract: Palliative radiation therapy (RT) can improve quality of life but also incurs time and financial costs. The aim of this study was to evaluate factors associated with use and intensity of palliative RT for incurable non-small cell lung cancer (NSCLC).
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-04-23
      DOI: 10.1016/j.adro.2018.04.005
       
  • Adjuvant treatment of meningioma with stereotactic radiosurgery and
           hypofractionated stereotactic radiosurgery: Patterns of care and survival
           in a large, hospital database

    • Authors: Ashley Albert; Anna Lee, Srinivasan Vijayakumar, Madhava Kanakamedala, Robert Allbright, David Schreiber
      Abstract: Stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiosurgery (HF-SRS) have recently become an alternative to external beam radiation therapy (EBRT) in the adjuvant treatment of meningiomas. The purpose of this study was to identify national treatment patterns and survival outcomes for meningiomas based on radiation treatment modality in the adjuvant setting.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-04-23
      DOI: 10.1016/j.adro.2018.04.004
       
  • Clinical outcomes and prognostic factors in patients with stage II-III
           breast cancer treated with neoadjuvant chemotherapy followed by surgery
           and postmastectomy radiotherapy in the modern treatment era

    • Authors: Naomi Nakajima; Masahiko Oguchi, Yasuko Kumai, Masahiro Yoshida, Hirotaka Inoda, Takuji Iwase, Yoshinori Ito, Futoshi Akiyama, Shinji Ohno, Teruhito Mochizuki
      Abstract: There are no randomized studies regarding the indication for postmastectomy radiotherapy (PMRT) in patients who receive neoadjuvant chemotherapy (NAC) followed by mastectomy. The aim of this study was to determine clinical outcomes and identify reliable prognostic factors in patients with locally advanced breast cancer treated with NAC followed by mastectomy and PMRT.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-04-20
      DOI: 10.1016/j.adro.2018.04.006
       
  • Initial experience with intensity modulated proton therapy for intact,
           clinically-localized pancreas cancer: clinical implementation, dosimetric
           analysis, acute treatment-related adverse events, and patient-reported
           outcomes

    • Authors: Krishan R. Jethwa; Erik J. Tryggestad, Thomas J. Whitaker, Broc T. Giffey, Bret D. Kazemba, Michelle A. Neben-Wittich, Kenneth W. Merrell, Michael G. Haddock, Christopher L. Hallemeier
      Abstract: Proton therapy for pancreas cancer may improve the therapeutic ratio for delivery of chemoradiation therapy. We performed a matched dosimetric comparison of intensity modulated proton therapy compared with volumetrically modulated arc therapy. Intensity modulated proton therapy allowed for significant reductions in mean and low-intermediate dose to organs at risk, and was associated with low rates of gastrointestinal adverse events and favorable patient reported outcomes of health-related quality of life.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-04-13
      DOI: 10.1016/j.adro.2018.04.003
       
  • Local failure and vertebral body fracture risk using multi-fraction SBRT
           for spine metastases

    • Authors: Nihaal Mehta; Peter J. Zavitsanos, Krisztina Moldovan, Adetokunbo Oyelese, Jared S. Fridley, Ziya Gokaslan, Timothy J. Kinsella, Jaroslaw T. Hepel
      Abstract: Single-fraction radiosurgery for spine metastases is highly effective. However, a high rate (20-39%) of vertebral body fracture (VBF) has been associated with large, single-fraction doses. We report our experience using multi-fraction stereotactic body radiotherapy (SBRT).
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-04-10
      DOI: 10.1016/j.adro.2018.04.002
       
  • Implementation and utilization of hypofractionation for breast cancer

    • Authors: Philip Gilbo; Louis Potters, Lucille Lee
      Abstract: INTRODUCTIONHypofractionation (HF) of whole breast irradiation has become a standard treatment regimen as randomized trials continue to demonstrate equivalence in survival and local control compared to conventional fractionation (CF). In 2011, ASTRO adopted clinical guidelines on the proper selection of HF. Nevertheless, utilization remains lower than predicted. We evaluate the effects of clinical directives serving as default treatment decisions and prospective contouring rounds on implementation of HF in a large, multicenter radiation oncology department.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-04-09
      DOI: 10.1016/j.adro.2018.04.001
       
  • Resident satisfaction with radiation oncology training

    • Authors: Awad A. Ahmed; Stephen J. Ramey, Mary K. Dean, Stella K. Yoo, Emma Holliday, Curtiland Deville, Cristiane Takita, Neha Vapiwala, Lynn D. Wilson, Reshma Jagsi, Charles R. Thomas, Raphael Yechieli
      Abstract: The majority of radiation oncology residents report satisfaction with their choice of residency program and an adequate work-life balance. Program dissatisfaction was strongly correlated with lack of resident-feedback use and senior resident status. Almost one-third (29.1%) of seniors regretted their residency program choice. Increased residency-program use of trainee recommendations regarding program improvement and assistance for seniors with the stresses of securing a job may increase satisfaction with training in radiation oncology.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-03-20
      DOI: 10.1016/j.adro.2018.03.003
       
  • Preservation of swallowing function with de-intensified chemoradiotherapy
           for HPV-associated oropharyngeal squamous cell carcinoma

    • Authors: Greg D. Judy; Rebecca Green, Shannon L. Aumer, Robert J. Amdur, Xianming Tan, Nathan Sheets, Mark Weissler, Adam Zanation, Samip Patel, Trevor Hackman, William M. Mendenhall, Bhishamjit S. Chera
      Abstract: To compare swallowing function in patients with HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) treated with de-intensified chemoradiotherapy (6 weeks, 60Gy) vs those receiving standard of care chemoradiotherapy (7 weeks, 70Gy).
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-03-14
      DOI: 10.1016/j.adro.2018.03.002
       
  • Model evaluation of rapid four-dimensional lung tomosynthesis

    • Authors: Joseph T. Rakowski
      Abstract: This is an investigation of a lung motion digital tomosynthesis (DTS) model using combined stationary detector and stationary cold cathode x-ray sources at projection acquisition rates exceeding present norms. The intent is to reduce anatomical uncertainties from artifacts inherent in thoracic four-dimensional computed tomography (4DCT).
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-03-08
      DOI: 10.1016/j.adro.2018.03.001
       
  • The virtual cone: a novel technique to generate spherical dose
           distributions using a multi-leaf collimator and standardized control-point
           sequence for small target radiosurgery

    • Authors: Richard A. Popple; Xingen Wu, Ivan A. Brezovich, James M. Markert, Barton L. Guthrie, Evan M. Thomas, Markus Bredel, John B. Fiveash
      Abstract: To develop and demonstrate a standardized linear accelerator multileaf collimator-based method of delivering small, spherical dose distributions suitable for radiosurgical treatment of small targets such as the trigeminal nerve.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-03-02
      DOI: 10.1016/j.adro.2018.02.011
       
  • Feasibility of definitive chemoradiotherapy with nedaplatin and
           5-fluorouracil in elderly patients with esophageal squamous cell
           carcinoma: a retrospective study

    • Authors: Akinori Watanabe; Chikatoshi Katada, Shouko Komori, Hiromitsu Moriya, Keishi Yamashita, Hiroki Harada, Mizutomo Azuma, Yuki Kondo, Yo Kubota, Yasuaki Furue, Natsuko Kawanishi, Sakiko Yamane, Takuya Wada, Takafumi Yano, Kenji Ishido, Satoshi Tanabe, Kazushige Hayakawa, Wasaburo Koizumi
      Abstract: This study was designed to retrospectively analyze the safety and efficacy of chemoradiotherapy with nedaplatin and 5-fluorouracil in elderly patients with esophageal squamous cell carcinoma.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-03-01
      DOI: 10.1016/j.adro.2018.02.010
       
  • The 2017 american society of radiation oncology (ASTRO) annual meeting:
           taking a deeper dive into social media

    • Authors: Miriam A. Knoll; Brian Kavanagh, Matthew Katz
      Abstract: In June 2017, ASTRO's board of directors revised and updated the organization's strategic plan. The directors reiterated that the core purpose of the organization is to advance the field of radiation oncology, and the overarching vision is that the field should be a recognized leader in quality, innovation and value in multidisciplinary cancer care.1 The strategic plan would be operationalized through four major areas of focus, the first of which was to “elevate the profile of the field” for the purpose of establishing radiation oncology as an equal partner in the field of cancer.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-02-26
      DOI: 10.1016/j.adro.2018.02.009
       
  • Updated strategies in the treatment of benign diseases– a patterns of
           care study of the german cooperative group on benign diseases.

    • Authors: J. Kriz; M.H. Seegenschmiedt, A. Bartels, O. Micke, R. Muecke, U. Schaefer, U. Haverkamp, H.T. Eich
      Abstract: Radiation therapy (RT) is a common treatment for benign diseases in Germany. Because the treatment concepts are inconsistent, we conducted this pattern of care study on behalf of the German Cooperative Group on Benign Diseases to evaluate the treatment standard in Germany.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-02-26
      DOI: 10.1016/j.adro.2018.02.008
       
  • A component of lobular carcinoma in clinically lymph node-negative
           patients predicts for an increased likelihood of upstaging to pathologic
           stage III breast cancer

    • Authors: Renae D. Van Wyhe; Abigail S. Caudle, Simona F. Shaitelman, George H. Perkins, Thomas A. Buchholz, Karen E. Hoffman, Eric A. Strom, Benjamin D. Smith, Welela Tereffe, Wendy A. Woodward, Michael C. Stauder
      Abstract: Physical exam and diagnostic imaging are often less precise in determining the extent of disease in invasive lobular carcinoma (ILC) relative to non-lobular histologies. Anecdotally, surgical axillary evaluation frequently reveals positive lymph nodes in clinically N0 patients with ILC; however, few studies quantify the likelihood of finding unsuspected disease at the time of surgery. Here, in patients with a clinically node-negative axilla and positive SLN biopsy, we evaluate whether the presence of lobular histology increases the incidence of surgical upstaging to pathologic stage IIIA or greater.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-02-26
      DOI: 10.1016/j.adro.2018.02.007
       
  • Multiple energy extraction reduces beam delivery time for a
           synchrotron-based proton spot-scanning system

    • Authors: James E. Younkin; Martin Bues, Terence T. Sio, Wei Liu, Xiaoning Ding, Sameer Keole, Joshua B. Stoker, Jiajian Shen
      Abstract: Multiple energy extraction (MEE) is a technology recently introduced by Hitachi for its spot scanning proton treatment system that allows multiple energies to be delivered in a single synchrotron spill. The purpose of this paper is to investigate by how much beam delivery time (BDT) can be reduced with MEE compared with single energy extraction (SEE) in which one energy is delivered per spill.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-02-23
      DOI: 10.1016/j.adro.2018.02.006
       
  • Initial toxicity, quality-of-life outcomes, and dosimetric impact in a
           randomized phase 3 trial of hypofractionated versus standard fractionated
           proton therapy for low-risk prostate cancer

    • Authors: Carlos E. Vargas; Matthew Q. Schmidt, William F. Hartsell, Sameer R. Keole, Lucius Doh, John Han-Chih Chang, Christopher Sinesi, Rossio Rodriquez, Gary L. Larson
      Abstract: Randomized evidence for extreme hypofractionation in prostate cancer is lacking. We aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and extreme hypofractionated radiation in a phase 3 randomized trial.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-02-23
      DOI: 10.1016/j.adro.2018.02.004
       
  • The role of bone marrow and spleen irradiation in the development of acute
           hematologic toxicity during chemoradiation for esophageal cancer

    • Authors: Alexander L. Chin; Sonya Aggarwal, Pooja Pradhan, Karl Bush, Rie von Eyben, Albert C. Koong, Daniel T. Chang
      Abstract: The purpose of this study was to determine the impact of splenic and thoracic bone marrow irradiation on hematologic toxicity in the setting of chemoradiation therapy for esophageal cancer.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-02-21
      DOI: 10.1016/j.adro.2018.02.005
       
  • Low-cost optical scanner and 3D printing technology to create lead
           shielding for radiotherapy of facial skin cancer: first clinical case
           series

    • Authors: Ankur Sharma; David Sasaki, Daniel W. Rickey, Ahmet Leylek, Chad Harris, Kate Johnson, Jorge E. Alpuche Aviles, Boyd McCurdy, Andy Egtberts, Rashmi Koul, Arbind Dubey
      Abstract: Three-dimensional (3D) printing has been implemented at our institution to create customized treatment accessories including lead shields used during radiotherapy for facial skin cancer. In order to effectively use 3D printing, the topography of the patient must first be acquired. We have evaluated a low-cost, structured-light 3D optical scanner in order to assess clinical viability of this technology.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-02-15
      DOI: 10.1016/j.adro.2018.02.003
       
  • Reasons of discontinued radiotherapy and effective countermeasures

    • Authors: Toshiya Maebayashi; Naoya Ishibashi, Takuya Aizawa, Masakuni Sakaguchi, Kenya Yamagushi
      Abstract: The proportion of patients receiving radiotherapy in Japan is less than half of those in Europe and the United States (1). The main reason for this is probably due to insufficient man power of radiation oncologists (2). Additionally, we consider the true reason of this might be an insufficient promotion of radiologists in radiotherapy to the clinicians of other fields. Completing a planned radiotherapy is an important factor for achieving a good outcome. However, sometimes radiotherapy is discontinued due to various reasons.
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-02-12
      DOI: 10.1016/j.adro.2018.02.001
       
  • Letter to the Editor in response to Hopper et al, “Salvage therapy for
           locally recurrent prostate cancer after radiation”

    • Authors: Adam Holtzman; Bradford S. Hoppe
      Abstract: We read with great interest the article by Hopper et al on salvage image-guided radiotherapy (IGRT) after failing cryotherapy among 8 patients with prostate cancer with no acute grade 2 toxicities.1
      Citation: Advances in Radiation Oncology (2018)
      PubDate: 2018-02-09
      DOI: 10.1016/j.adro.2018.02.002
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.163.20.57
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-